First Time Loading...

Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 0.636 USD 6.46% Market Closed
Updated: May 23, 2024

Sangamo Therapeutics Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sangamo Therapeutics Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Sangamo Therapeutics Inc
NASDAQ:SGMO
PP&E Net
$43m
CAGR 3-Years
-28%
CAGR 5-Years
-2%
CAGR 10-Years
41%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.5B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
7%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.2B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
22%

See Also

What is Sangamo Therapeutics Inc's PP&E Net?
PP&E Net
43m USD

Based on the financial report for Mar 31, 2024, Sangamo Therapeutics Inc's PP&E Net amounts to 43m USD.

What is Sangamo Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
41%

Over the last year, the PP&E Net growth was -60%. The average annual PP&E Net growth rates for Sangamo Therapeutics Inc have been -28% over the past three years , -2% over the past five years , and 41% over the past ten years .